{"id":69,"kind":"story","title":"Three Billion Launches Genetic Diagnostic SaaS at ACMG","url":"https://www.venturesquare.net/1045064/","host":"venturesquare.net","by":"mrlatte","score":1,"comments":0,"time":"2026-03-11T12:46:38.000Z","origin":"archive","language":{"source":"ko","reading":"en","translated":true},"summary":["Three Billion will showcase its genetic variant interpretation SaaS platform, GEBRA, at ACMG 2026 in the United States.","Instead of developing diagnostic equipment, they focus on data interpretation software targeting overseas medical professionals and research institutes.","This approach is noteworthy for startup teams burdened by device development.","However, to move from being introduced at a conference to repeated use by clinicians, accuracy and reliability must be proven in real-world practice."],"discussion":"https://startupxo.com/en/69/","markdown":"https://startupxo.com/en/69.md","api":"https://startupxo.com/api/v1/item.json?id=69&lang=en","text":null,"edited":null,"sources":[],"thread":[]}